<ENAMEX TYPE="PERSON">Jon S. Saxe</ENAMEX>, 53 years old, was named president and chief executive officer of this pharmaceuticals and animal health products company, succeeding <ENAMEX TYPE="PERSON">Larry Soll</ENAMEX>, 47, a founder of the company who will remain as chairman and continue an active role in the company. Mr. <ENAMEX TYPE="PERSON">Saxe</ENAMEX>, who is currently vice president, licensing and corporate development, at <ENAMEX TYPE="ORGANIZATION">Hoffmann</ENAMEX>-<ENAMEX TYPE="ORGANIZATION">La Roche Inc.</ENAMEX>, was also elected to the board, increasing the board's size to eight.
